| |
Cardiac event (+)
(n=107cases) |
Cardiac event(-)
(n=505cases) |
Range |
p-value |
| Age（y.o） |
63.1±12.4 |
62.3±13.6 |
25~85 |
p=0.7609 |
| Sex（M/F） |
76/31 |
387/118 |
|
p=0.2268 |
| NYHA functional class (Ⅰ/Ⅱ/Ⅲ/Ⅳ) |
49/23/24/11 |
351/99/50/5 |
|
p<0.0001 |
| Hypertension |
38 (35.5%) |
179 (35.4%) |
|
p=0.9997 |
| Diabetes mellitus |
37 (34.5%) |
135 (26.7%) |
|
p=0.1091 |
| Dyslipidemia |
15( 14.0%) |
178 (35.2%) |
|
p<0.0001 |
| Atrial fibrillation |
22 (20.5%) |
148 (29.3%) |
|
p=0.570 |
| Ventricular tachycardia Ventricular fibrillation |
35 (32.7%) |
123 (24.3%) |
|
p=0.826 |
| IHD |
48( 44.8%) |
224 (44.3%) |
|
p=0.9242 |
| p/o PCI |
20 (18.7%) |
122 (24.2%) |
|
p=0.2072 |
| p/o CABG |
15 (14.0%) |
66 (13.0%) |
|
p=0.8050 |
| HCM |
3 ( 2.7% ) |
13 ( 9.7% ) |
|
p=0.7051 |
| DCM |
55 (51..4%) |
240 (47.5%) |
|
p=0.7331 |
| Valvular heart disease |
1 (0.9%) |
28 (5.5%) |
|
p=0.0677 |
| BNP concentration (pg/ml) |
543±608.3 |
309.4±419.3 |
30.2~4800 |
p=0.0002 |
| Hemoglobin level (g/dl) |
11.8±1.7 |
13.3±1.8 |
7.9~17.5 |
p<0.0001 |
| Esimated GFR (ml/min/1.73m2) |
46.5±18.3 |
56.6±21.5 |
20.2~129.3 |
p<0.0001 |
| Sodium (mmol/L) |
139.4±3.6 |
140.1±3.3 |
130~148 |
p=0.0683 |
